Delivery Order SPE2DB20D1109-SPE2DB22FP53X

Award Date 6/30/22
Potential Completion Date 7/1/22
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,546.86 firm-fixed-price contract has a completion date of November 5, 2024, and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA). The $22,780.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 16, 2024 with a completion date of May 17, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $5,738.23 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 20, 2022, with a completion date of July 21, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $14,592.15 and an ultimate completion date of December 24, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $2,864.02 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024. The contract has an ultimate completion date of June 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 6, 2024, with a ceiling value of $2,770.74 and a completion date of September 9, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA). The $2,866.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 4, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. The IDC...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,174.46, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA). The $7,033.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,388.75 and an ultimate completion date of December 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FP53X
    Delivery Order

This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,365.48 firm fixed-price contract was awarded on June 30, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 1, 2022. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:26 AM